Microbial Musings – November 2021

References

1. Thomas GH. Microbial musings – July 2020. Microbiology 2020; 166:594–596 [View Article]
   [Google Scholar]
2. Evangelista AG, Corrêa JAF, Dos Santos JVG, Matté EHC, Milek MM et al. Cell-free supernatants produced by lactic acid bacteria reduce Salmonella population in vitro . Microbiology 2021; 167: [View Article] [PubMed]
   [Google Scholar]
3. Klose V, Bayer K, Bruckbeck R, Schatzmayr G, Loibner AP. In vitro antagonistic activities of animal intestinal strains against swine-associated pathogens. Vet Microbiol 2010; 144:515–521 [View Article] [PubMed]
   [Google Scholar]
4. De Keersmaecker SCJ, Verhoeven TLA, Desair J, Marchal K, Vanderleyden J et al. Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid. FEMS Microbiol Lett 2006; 259:89–96 [View Article] [PubMed]
   [Google Scholar]
5. Stone NRH, Woodford N, Livermore DM, Howard J, Pike R et al. Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis. J Antimicrob Chemother 2011; 66:2677–2678 [View Article] [PubMed]
   [Google Scholar]
6. Franklin TJ, Snow GA. Biochemistry and molecular biology of antimicrobial drug action. In Biochemistry and Molecular Biology of Antimicrobial Drug Action, 5th ed. Boston, MA: Kluwer Academic Publishers; 1998 [View Article]
   [Google Scholar]
7. Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev 2017; 30:557–596 [View Article] [PubMed]
   [Google Scholar]
8. Imai Y, Meyer KJ, Iinishi A, Favre-Godal Q, Green R et al. A new antibiotic selectively kills Gram-negative pathogens. Nature 2019; 576:459–464 [View Article] [PubMed]
   [Google Scholar]
9. Janssen AB, van Schaik W. Harder, better, faster, stronger: Colistin resistance mechanisms in Escherichia coli . PLoS Genet 2021; 17:7–10 [View Article] [PubMed]
   [Google Scholar]
10. Dixon RA, Chopra I. Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Escherichia coli . J Antimicrob Chemother 1986; 18:557–563 [View Article] [PubMed]
    [Google Scholar]
11. Sabnis A, Hagart KL, Klöckner A, Becce M, Evans LE et al. Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane. elife 2021; 10:e65836 [View Article] [PubMed]
    [Google Scholar]
12. MacNair CR, Stokes JM, Carfrae LA, Fiebig-Comyn AA, Coombes BK et al. Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics. Nat Commun 2018; 9:1–8 [View Article] [PubMed]
    [Google Scholar]
13. Yu Y, Walsh TR, Yang R-S, Zheng M, Wei M-C et al. Novel partners with colistin to increase its in vivo therapeutic effectiveness and prevent the occurrence of colistin resistance in NDM- and MCR-co-producing Escherichia coli in a murine infection model. J Antimicrob Chemother 2019; 74:87–95 [View Article] [PubMed]
    [Google Scholar]
14. Bradley JM, Le Brun NE, Moore GR. Ferritins: furnishing proteins with iron. J Biol Inorg Chem 2016; 21:13–28 [View Article] [PubMed]
    [Google Scholar]
15. Bradley JM, Svistunenko DA, Pullin J, Hill N, Stuart RK et al. Reaction of O2 with a diiron protein generates a mixed-valent Fe2+/Fe3+ center and peroxide. Proc Natl Acad Sci U S A 2019; 116:2058–2067 [View Article] [PubMed]
    [Google Scholar]
16. Bradley JM, Pullin J, Moore GR, Svistunenko DA, Hemmings AM et al. Routes of iron entry into, and exit from, the catalytic ferroxidase sites of the prokaryotic ferritin SynFtn. Dalton Trans 2020; 49:1545–1554 [View Article] [PubMed]
    [Google Scholar]
17. Thomas GH. Microbial Musings - October 2021. Microbiology (Reading) 2021; 167:001129 [View Article] [PubMed]
    [Google Scholar]
18. Douglas EJA, Duggan S, Brignoli T, Massey RC. The MpsB protein contributes to both the toxicity and immune evasion capacity of Staphylococcus aureus. Microbiology 2021; 167: [View Article] [PubMed]
    [Google Scholar]
19. Recker M, Laabei M, Toleman MS, Reuter S, Saunderson RB et al. Clonal differences in Staphylococcus aureus bacteraemia-associated mortality. Nat Microbiol 2017; 2:1381–1388 [View Article] [PubMed]
    [Google Scholar]
20. Boyle-Vavra S, Li X, Alam MT, Read TD, Sieth J et al. USA300 and USA500 clonal lineages of Staphylococcus aureus do not produce a capsular polysaccharide due to conserved mutations in the cap5 locus. mBio 2015; 6:e02585-14 [View Article]
    [Google Scholar]
21. Mohamed N, Timofeyeva Y, Jamrozy D, Rojas E, Hao L et al. Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United States. PLoS One 2019; 14:e0208356 [View Article] [PubMed]
    [Google Scholar]
22. Proctor RA. Challenges for a universal Staphylococcus aureus vaccine. Clin Infect Dis 2012; 54:1179–1186 [View Article] [PubMed]
    [Google Scholar]
23. Kohler C, von Eiff C, Liebeke M, McNamara PJ, Lalk M et al. A defect in menadione biosynthesis induces global changes in gene expression in Staphylococcus aureus . J Bacteriol 2008; 190:6351–6364 [View Article] [PubMed]
    [Google Scholar]
24. Lannergård J, von Eiff C, Sander G, Cordes T, Seggewiss J et al. Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus . Antimicrob Agents Chemother 2008; 52:4017–4022 [View Article] [PubMed]
    [Google Scholar]